Category: Uncategorized

Recent studies highlight semaglutide, a GLP-1 receptor agonist used for weight loss and cardiovascular benefits, may lead to unintended reductions in skeletal and cardiac muscle mass, raising concerns about its long-term effects, especially for patients with or at risk for heart failure.

Key Findings:

1. Body Weight and Muscle Loss:
   • Mice treated with semaglutide experienced significant weight loss (~30%) and a reduction in fat mass (~65%).
   • Skeletal muscle mass decreased by 8.2% in lean mice, consistent with prior findings in obese mice.
2. Cardiac Muscle Impact:
   • Semaglutide reduced left ventricular (LV) mass, heart weight, and cardiomyocyte size in mice.
   • These changes occurred without affecting cardiac function (ejection fraction) or fibrosis-related gene activity.
   • Cultured human cardiomyocytes treated with semaglutide also showed reduced size, suggesting a direct effect on cardiac cells.
3. Potential Risks:
   • In non-hypertrophic conditions, semaglutide-induced reductions in cardiac mass could potentially lead to long-term detrimental effects, such as exercise intolerance or worsened outcomes in heart failure patients.
   • However, in hypertrophic settings, GLP-1RAs have shown benefits in reducing excessive cardiac mass.
4. Implications for Human Use:
   • While the metabolic benefits of semaglutide may outweigh these risks in many cases, the study suggests that cardiac structure and function should be carefully monitored in patients using GLP-1RAs, particularly those with existing cardiovascular disease (CVD) or cardiac hypertrophy.
   • Further clinical studies are necessary to confirm these findings in humans and evaluate potential long-term effects.

Conclusion:

Semaglutide may have unintended consequences for muscle mass, including cardiac muscle. These findings highlight the importance of monitoring cardiac health in individuals using GLP-1RAs, especially as their use expands among diverse population

Want to find out if you or a loved one has a GLP-1 claim?

Please feel free to contact a GLP-1 Lawsuit attorney at info@westrikeback.com or 1-877-542-4646. One of our experienced GLP-1 Lawsuit lawyers will help evaluate your claim and explain your legal rights for free. McSweeney / Langevin is providing consultations to individuals throughout the United States. Information provided by email or phone will be kept confidential.

A recent study estimates that over half of U.S. adults, approximately 136.8 million people, are eligible for semaglutide (Ozempic, Wegovy, Rybelsus) based on its approved indications for diabetes, weight management, and secondary cardiovascular disease (CVD) prevention. This exceeds the number of adults eligible for statins, highlighting semaglutide’s widespread applicability.

Key findings include:

Please feel free to contact a GLP-1 Lawsuit attorney at info@westrikeback.com or 1-877-542-4646. One of our experienced GLP-1 Lawsuit lawyers will help evaluate your claim and explain your legal rights for free. McSweeney / Langevin is providing consultations to individuals throughout the United States. Information provided by email or phone will be kept confidential.

Approximately 39.3 million eligible adults qualify for non-weight management indications, which often have better insurance coverage. However, affordability remains a barrier, with many users reporting difficulty affording GLP-1 receptor agonists.

Semaglutide, approved for type 2 diabetes in 2017, later gained approval for chronic weight management and cardiovascular risk reduction in individuals with obesity or overweight and related conditions. All uses require a reduced-calorie diet and exercise regimen.

With increased popularity of GLP-1 drugs to treat obesity and diabetes, concern has risen that use may come with serious side effects. Our firm is currently investigating GLP-1 lawsuits.

Want to find out if you or a loved one has a GLP-1 claim?

Please feel free to contact a GLP-1 Lawsuit attorney at info@westrikeback.com or 1-877-542-4646. One of our experienced GLP-1 Lawsuit lawyers will help evaluate your claim and explain your legal rights for free. McSweeney / Langevin is providing consultations to individuals throughout the United States. Information provided by email or phone will be kept confidential.

• Weight management: 129.2 million adults are eligible, with 97.5 million qualifying solely for this indication.
• Diabetes: 35 million adults qualify, 7.6 million exclusively.
• Secondary CVD prevention: 8.9 million qualify, all overlapping with other indications.

Approximately 39.3 million eligible adults qualify for non-weight management indications, which often have better insurance coverage. However, affordability remains a barrier, with many users reporting difficulty affording GLP-1 receptor agonists.

Semaglutide, approved for type 2 diabetes in 2017, later gained approval for chronic weight management and cardiovascular risk reduction in individuals with obesity or overweight and related conditions. All uses require a reduced-calorie diet and exercise regimen.

With increased popularity of GLP-1 drugs to treat obesity and diabetes, concern has risen that use may come with serious side effects. Our firm is currently investigating GLP-1 lawsuits.

Want to find out if you or a loved one has a GLP-1 claim?

Please feel free to contact a GLP-1 Lawsuit attorney at info@westrikeback.com or 1-877-542-4646. One of our experienced GLP-1 Lawsuit lawyers will help evaluate your claim and explain your legal rights for free. McSweeney / Langevin is providing consultations to individuals throughout the United States. Information provided by email or phone will be kept confidential.

A California federal judge ruled Meta Platforms, Google, ByteDance, and Snap Inc. must face most public nuisance claims in multidistrict litigation brought by school districts and local governments. These plaintiffs allege the companies designed their social media platforms—Facebook, Instagram, YouTube, TikTok, and Snapchat—to foster compulsive use by minors, leading to harmful effects on youth mental health and increased financial burdens on schools to address these issues.

The judge rejected the companies’ arguments public nuisance claims require a direct link to land use or product liability laws. She found the claims plausible, stating public nuisance law is flexible enough to address evolving harms.

The judge also supported the school districts’ claims of unique harm, distinguishing their resource expenditures to address mental health crises and social media’s disruptive effects in schools from generalized public harm. She held plaintiffs can seek abatement for the alleged nuisance.

The first trials in the litigation are scheduled for October 2025. Plaintiffs’ attorneys assert the addictive design of these platforms has disrupted education and harmed youth, while companies like Meta and Google deny the allegations, highlighting their efforts to create safer experiences for young users.

Microsoft,accused of creating dangerous and addictive video games, owns a vast array of video game franchises across various genres, primarily through its gaming division, Microsoft Gaming. This division includes several key subsidiaries:

Xbox Game Studios: Responsible for developing and publishing some of the
biggest franchises in history, including:

• Halo: A flagship first-person shooter series featuring the iconic Master
Chief.
• Forza: A racing series encompassing both the simulation-focused Forza
Motorsport and the open-world Forza Horizon.
• Gears of War: A third-person shooter series known for its intense combat and
storytelling.
• Minecraft: A sandbox game that has become a cultural phenomenon, allowing
players to build and explore virtual worlds.
• Fable: An action role-playing series set in a fantasy world.
• Age of Empires: A real-time strategy series that spans various historical
periods.

Bethesda Softworks: Acquired by Microsoft in 2021, Bethesda brings
several renowned franchises:• The Elder Scrolls: An open-world role-playing series, with Skyrim being one
of the best-selling games of all time.
• Fallout: A post-apocalyptic role-playing series known for its expansive
worlds and deep narratives.
• Doom: A pioneering first-person shooter series that has influenced the genre
since the 1990s.
• Wolfenstein: A series of first-person shooters set in an alternate history
where the Nazis won World War II.
• Dishonored: An action-adventure series known for its stealth mechanics and
immersive storytelling.

Activision Blizzard: Microsoft completed its acquisition of Activision
Blizzard in October 2023, adding several major franchises:• Call of Duty: A leading first-person shooter series with annual releases and
a massive player base.
• World of Warcraft: A groundbreaking massively multiplayer online role-playing
game (MMORPG).
• Diablo: An action role-playing series known for its dark fantasy themes.
• Overwatch: A team-based multiplayer first-person shooter with a diverse
roster of characters.
• StarCraft: A real-time strategy series set in a science fiction universe.
• Candy Crush: A popular mobile puzzle game series.

Cost of Hiring a Video Game Addiction Lawyer

Hiring our firm costs nothing upfront. We work on a contingency fee basis, meaning you only pay if we receive compensation. If you win, our fee will be a percentage of the settlement pr verdict, so there are no out-of-pocket expenses unless we succeed.

Feel free to contact one of our attorneys at 1-877-542-4646 or by using the form below if your family has suffered any adverse side effects due to a video game addiction. Your information will remain confidential, and a lawyer will provide a free legal consultation.

Information is key. Acquiring as much information and proof as possible, as soon as possible, can make the difference between success and failure.

Types of evidence necessary to prove video game addiction include:

Medical and/or psychological records containing a diagnosis of mental health or physical injury linked to gaming.

Financial records establishing excessive (amount, number of transactions, etc.) payments for video game related purchases.

Gaming logs (help by the manufacturer, host, etc. of the video game) indicating excessive game usage. Take screen shots, screen recordings, photos, videos, etc. if you have access to this information.

School records establishing poor grades, poor attendance, behavior issues, etc. Acquire these records if you have access.

Issues with sports or extracurricular activities described by coaches, supervisors, etc. in letters, emails, meetings, etc. Acquire and/or save all writings describing any possible video game related issues.

Written statements (email, letter, etc.) from family, friends, doctors, coaches, teachers, etc.

Obviously we will help acquire as much proof as possible if we are retained. Hiring our firm costs nothing upfront. We work on a contingency fee basis, meaning you only pay if we receive compensation. If you win, our fee will be a percentage of the settlement or verdict, so there are no out-of-pocket expenses unless we succeed.

Feel free to contact one of our video game addiction attorneys at 1-877-542-4646 or by using one of our electronic forms if your family has suffered any adverse side effects due to a video game addiction. Your information will remain confidential, and a lawyer will provide a free legal consultation.

Video game addiction, officially recognized as a mental health issue by the World Health Organization in 2018, affects around 15% of gamers, with 4% developing pathological addiction. This issue is especially prevalent among adolescents and young adults (ages 15–34). Gaming addiction ranges from mild to severe and is characterized by compulsive gaming despite negative impacts on personal, educational, or professional life.

Signs of Video Game Addiction include:

• Unsuccessful attempts to stop gaming
• Preoccupation with gaming
• Gaming to escape problems
• Neglecting responsibilities, personal hygiene, and health

Parents often try to address their child’s gaming issues, which can be challenging as many young people don’t recognize gaming as a problem. Effective intervention strategies include collaborative approaches, setting family gaming limits, and modeling healthy behaviors.

In severe cases, professional help may be necessary. Specialists can provide tools to manage gaming addiction, address underlying issues, and encourage healthy behaviors.

McSweeney / Langevin is providing legal advice and representation to families harmed by video game addiction.

The court denied AstraZeneca’s motion to dismiss a lawsuit filed by Brianne Dressen, who alleges she suffered severe side effects from AstraZeneca’s COVID-19 vaccine, administered during a clinical trial. Dressen’s claims include breach of contract and breach of the duty of good faith and fair dealing, arguing that AstraZeneca failed to cover her medical expenses as outlined in her informed consent form (ICF).

Key points include:

PREP Act Immunity: AstraZeneca argued the Public Readiness and Emergency Preparedness (PREP) Act, which limits liability for covered entities during public health emergencies, should bar Dressen’s claims. The court disagreed, ruling the PREP Act immunity does not cover breach of contract claims. The court reasoned a contract breach arises from a failure to perform a legal obligation, not directly from the countermeasure (the vaccine), and thus lacks the causal link necessary for PREP Act immunity.

Breach of Contract Claim: AstraZeneca argued Dressen’s claim should be reclassified under the Utah Product Liability Act with a shorter statute of limitations. The court rejected this, noting Dressen’s claim was based on contract terms, not a defective product. The economic loss rule, which restricts tort claims to contract-based remedies when duties stem from a contract, further supports Dressen’s position.

Breach of Duty of Good Faith: AstraZeneca challenged this claim as “meritless.” However, the court found Dressen plausibly alleged AstraZeneca’s delays harmed her right to the benefits of their agreement, stating that such a duty is inherent in contracts.

The court’s decision underscores the limited reach of PREP Act immunity and affirms breach of contract claims tied to vaccine side effects can proceed independently of product liability laws.

McSweeney / Langevin continues to investigate potential claims related to medical countermeasures discussed and allegedly covered by the PREP Act.

Litigation involving Depo-Provera, a contraceptive injection, is intensifying due to claims its U.S. warning labels lack key safety information included in other countries. The lawsuits argue the U.S. label fails to mention the increased risk of developing intracranial meningiomas—brain tumors warned about in both European and Canadian Depo-Provera labels.

The lawsuits cite a recent British Medical Journal (BMJ) study indicating long-term Depo-Provera users may be over five times more likely to develop meningiomas than average. Plaintiffs allege experiencing severe symptoms such as headaches, memory loss, and vision issues, which led to tumor diagnoses.

Plaintiffs accuse manufacturers Pfizer and Viatris of negligence for not including the tumor risk on U.S. labels, despite warnings on international labels. With over 70 million Depo-Provera users worldwide in 2019, awareness of potential risks is growing, and new cases are being accepted as litigation expands.

McSweeney / Langevin is providing legal advice and representation to individuals harmed by Depo-Provera.

A California federal judge dismissed claims against Mark Zuckerberg in a lawsuit accusing Meta of concealing the risks of social media on young users. The judge found the plaintiffs did not prove Zuckerberg’s direct involvement or authorization in hiding risks, which is required for holding him liable as a corporate officer. General claims about his control over Meta were deemed insufficient. Although future evidence could show more direct participation, the current allegations don’t meet the standard for corporate-officer liability.

This multidistrict litigation (MDL) involves claims from personal injury plaintiffs, school districts, local governments, and state attorneys general, alleging platforms like Facebook, Instagram, YouTube, TikTok, and Snapchat were designed to be addictive, harming minors and impacting public health. While the claims against Zuckerberg were dismissed, the case against Meta continues. Lead plaintiffs’ attorneys emphasize they will pursue discovery to prove the prioritization of profit over safety. Judge Gonzalez Rogers has ruled Meta and other social media companies must still face most of the claims related to child addiction brought by school districts and other entities.

The case is In re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation, No. 4:22-md-03047, in the Northern District of California.

Ozempic, a diabetes drug containing semaglutide, gained popularity for weight loss; however, new research published in The Lancet suggests Ozempic may lead to muscle loss, with higher rates of non-fat tissue loss compared to other weight-loss methods.